在结直肠癌的攻击性中识别与进展相关的LncRNAs
Wei Xi1, Xinxin Sun2, Mingwei Wang3
1Department of Oncology, Liaocheng People's Hospital, Liaocheng, 252000, Shandong, China.
Scientific reports
|May 18, 2025
概括
研究人员确定了关键的长非编码RNAs (lncRNAs),对于结直肠癌 (CRC) 进展至关重要. 这些lncRNAs具有作为生物标志物和治疗点的潜力,可以改善CRC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 结肠直肠癌 (CRC) 的进展是由复杂的分子变化驱动的,包括改变的长非编码RNA (lncRNA) 表达.
- 了解lncRNAs在CRC病变发生中的作用对于开发新型诊断和治疗策略至关重要.
研究的目的:
- 确定和描述与结直肠癌进展相关的关键 lncRNA.
- 研究CRC中这些与进展相关的lncRNAs的调控作用和预后意义.
主要方法:
- 来自癌症基因组图谱 (TCGA) 和单细胞RNA测序 (scRNA-seq) 的综合转录组数据.
- 开发了一种结合差异表达,生存分析和进展特征的评分系统,以优先考虑lncRNAs.
- 根据lncRNA表达特征进行实验验证和分析患者子组.
主要成果:
- 在CRC中确定了198个关键的与进展相关的lncRNA,包括已知的 (LINC01615) 和新的候选者 (AC007998.3).
- 确认了在CRC组织中选择的lncRNAs的差异表达,并阐明了它们的调节机制 (cis-, trans-, post-transcriptional).
- 证明lncRNA表达模式定义了不同的CRC分子子组,具有不同的预后和免疫微环境.
结论:
- 与进展相关的lncRNAs在CRC中显著丰富于差异表达的lncRNAs,突出显示了它们的功能重要性.
- 这些已识别的lncRNAs作为强大的预后生物标志物和结直肠癌的潜在治疗点.
- 这项研究为CRC进展的分子格局及其对患者结果的影响提供了新的见解.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K


